M. Papadaki

发表

Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients

Harris Markomanolaki, G. Kallergi, D. Mavroudis, 2013, Molecular Cancer Therapeutics.

1 Apoptotic Circulating Tumor Cells ( CTCs ) in early and metastatic breast cancer patients

Harris Markomanolaki, G. Kallergi, D. Mavroudis, 2013 .

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Harris Markomanolaki, G. Kallergi, V. Georgoulias, 2015, PloS one.

Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients

V. Georgoulias, N. Xenidis, A. Kotsakis, 2021, AntiCancer Research.

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients

Harris Markomanolaki, G. Kallergi, D. Mavroudis, 2009, Breast Cancer Research.

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

D. Mavroudis, V. Georgoulias, S. Agelaki, 2018, Molecular Cancer Therapeutics.

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

G. Kallergi, D. Mavroudis, V. Georgoulias, 2014, BMC Cancer.

Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

M. Tzardi, D. Mavroudis, S. Agelaki, 2020, Cancers.

Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index

A. Soldatou, L. Michala, A. Garoufi, 2021, Children.

Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study

A. Mitsioni, A. Garoufi, D. Gourgiotis, 2022, Children.

Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate

S. Agelaki, D. Mavroudis, M. Papadaki, 2022, Cancers.

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab

S. Agelaki, D. Mavroudis, K. Michaelidou, 2022, Cancers.

Role of circulating miRNAs in detecting metastasis and having prognostic significance in metastatic breast cancer.

G. Markakis, S. Agelaki, D. Mavroudis, 2018 .

Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs.

K. Alevizopoulos, K. Dimas, C. Demetzos, 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients

G. Kallergi, D. Mavroudis, V. Georgoulias, 2015, Breast Cancer Research.

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

S. Agelaki, G. Kallergi, D. Mavroudis, 2011, Breast Cancer Research.

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications

S. Agelaki, D. Mavroudis, K. Michaelidou, 2022, Cancers.

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

S. Agelaki, D. Mavroudis, A. Koutsopoulos, 2020, Cancers.

Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy

S. Agelaki, D. Mavroudis, K. Rounis, 2020, Cancers.

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

S. Agelaki, D. Mavroudis, C. Papadaki, 2019, Oncotarget.

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

V. Georgoulias, S. Agelaki, D. Mavroudis, 2021, International journal of molecular sciences.

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer

S. Agelaki, D. Mavroudis, K. Mavridis, 2020, Cells.

Development of an in vitro homeostasis model between airway epithelial cells, bacteria and bacteriophages: a time-lapsed observation of cell viability and inflammatory response.

N. Papadopoulos, C. Akdis, E. Andreakos, 2022, The Journal of general virology.

Abstract P1-04-08: Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

S. Agelaki, G. Kallergi, V. Georgoulias, 2013 .

MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer

Christoforos Nikolaou, S. Agelaki, D. Mavroudis, 2021, Biomedicines.

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer

S. Agelaki, M. Papadaki, 2022, Cancers.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

MicroRNAs involved in immune response as prognostic markers in early and metastatic breast cancer.

S. Agelaki, D. Mavroudis, K. Kalbakis, 2020 .

A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19

D. Fotiadis, N. Rovina, A. Koutsoukou, 2021, Diagnostics.

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients

G. Kallergi, D. Mavroudis, V. Georgoulias, 2015, Breast Cancer Research.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

Laura E. Covill, P. Gregersen, J. Casanova, 2022, The Journal of experimental medicine.

Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells.

L V McIntire, K. Nguyen, L. McIntire, 1998, Circulation research.

Abstract 2397: Evaluation of proliferation and apoptosis markers in circulating tumor cells (CTCs) of women with early breast cancer who are candidates for tumor dormancy

Vassilis Georgoulias, Harris Markomanolaki, Sofia Agelaki, 2012 .